Bleichroeder LP’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-971
| Closed | -$2.52K | – | 82 |
|
|
2024
Q1 | $2.52K | Hold |
971
| – | – | ﹤0.01% | 79 |
|
|
2023
Q4 | $3.5K | Hold |
971
| – | – | ﹤0.01% | 71 |
|
|
2023
Q3 | $5.03K | Hold |
971
| – | – | ﹤0.01% | 67 |
|
|
2023
Q2 | $8.28K | Sell |
971
-26,043
| -96% | -$267K | ﹤0.01% | 77 |
|
|
2023
Q1 | $318K | Hold |
27,014
| – | – | 0.07% | 41 |
|
|
2022
Q4 | $389K | Hold |
27,014
| – | – | 0.08% | 41 |
|
|
2022
Q3 | $1.35M | Hold |
27,014
| – | – | 0.28% | 34 |
|
|
2022
Q2 | $2.3M | Hold |
27,014
| – | – | 0.48% | 31 |
|
|
2022
Q1 | $4.08M | Hold |
27,014
| – | – | 0.72% | 31 |
|
|
2021
Q4 | $8.08M | Hold |
27,014
| – | – | 1.26% | 21 |
|
|
2021
Q3 | $10.5M | Hold |
27,014
| – | – | 1.71% | 18 |
|
|
2021
Q2 | $11.4M | Hold |
27,014
| – | – | 1.72% | 18 |
|
|
2021
Q1 | $13.1M | Buy |
+27,014
| New | +$13.8M | 2.21% | 14 |
|